Össur hf (CPH:OSSR) reported on Monday that under its share buy back programme, it has acquired 853,424 shares at the average price of DKK51.59.
The company said that on 26 November 2019, it initiated a share buy-back programme, the purpose of which is to reduce the company's share capital and adjust the capital structure by distributing capital to shareholders in line with the company's capital structure and dividend policy.
This programme will end no later than 11 March 2020. The company may purchase up to 5,000,000 shares under the programme, corresponding to 1.2% of the current share capital. The total consideration for shares purchased under the programme shall not exceed USD10m.
Following this repurchase, Össur's holding of own shares is 3,809,635 corresponding to 0.90% of the company's total share capital.
Össur provides non-invasive orthopaedics and is focused on improving people's mobility through the delivery of innovative technologies within the fields of prosthetics and bracing and supports.
(EUR1.00=DKK7.47)
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development